These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1905383)

  • 1. L-threonine as a symptomatic treatment for amyotrophic lateral sclerosis (ALS).
    Roufs JB
    Med Hypotheses; 1991 Jan; 34(1):20-3. PubMed ID: 1905383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anomaly in the neurotransmitter amino acids in amyotrophic lateral sclerosis: a therapeutic application].
    Blin O; Desnuelle C; Guelton C; Aubrespy G; Ardissonne JP; Crevat A; Pouget J; Serratrice G
    Rev Neurol (Paris); 1991; 147(5):392-4. PubMed ID: 1677212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind placebo-controlled trial of L-threonine in amyotrophic lateral sclerosis.
    Blin O; Pouget J; Aubrespy G; Guelton C; Crevat A; Serratrice G
    J Neurol; 1992 Feb; 239(2):79-81. PubMed ID: 1313078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acids for amyotrophic lateral sclerosis / motor neuron disease.
    Parton M; Mitsumoto H; Leigh PN
    Cochrane Database Syst Rev; 2003; (4):CD003457. PubMed ID: 14583978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data.
    Tandan R; Bromberg MB; Forshew D; Fries TJ; Badger GJ; Carpenter J; Krusinski PB; Betts EF; Arciero K; Nau K
    Neurology; 1996 Nov; 47(5):1220-6. PubMed ID: 8909433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Short-term double-blind vs placebo trial of L-threonine in amyotrophic lateral sclerosis].
    Blin O; Serratrice G; Pouget J; Aubrespy G; Guelton C; Crevat A
    Presse Med; 1989 Sep; 18(30):1469-70. PubMed ID: 2534171
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic treatment with L-threonine in amyotrophic lateral sclerosis: a pilot study.
    Testa D; Caraceni T; Fetoni V; Girotti F
    Clin Neurol Neurosurg; 1992; 94(1):7-9. PubMed ID: 1353011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
    Pryce G; Baker D
    Handb Exp Pharmacol; 2015; 231():213-31. PubMed ID: 26408162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant treatment for amyotrophic lateral sclerosis.
    Simpson EP
    Lancet Neurol; 2005 May; 4(5):266. PubMed ID: 15847835
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
    Zoccolella S; Simone IL; Lamberti P; Samarelli V; Tortelli R; Serlenga L; Logroscino G
    Neurology; 2008 Jan; 70(3):222-5. PubMed ID: 18195267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis: a neurovascular disease.
    Garbuzova-Davis S; Rodrigues MC; Hernandez-Ontiveros DG; Louis MK; Willing AE; Borlongan CV; Sanberg PR
    Brain Res; 2011 Jun; 1398():113-25. PubMed ID: 21632035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis.
    Plaitakis A
    Ann Neurol; 1990 Jul; 28(1):3-8. PubMed ID: 1973889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosis.
    Whittle AJ; Ross OA; Naini A; Gordon P; Mistumoto H; Dächsel JC; Stone JT; Wszolek ZK; Farrer MJ; Przedborski S
    J Neural Transm (Vienna); 2007 Mar; 114(3):327-9. PubMed ID: 16865326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyotrophic lateral sclerosis from bench to bedside.
    Lomen-Hoerth C
    Semin Neurol; 2008 Apr; 28(2):205-11. PubMed ID: 18351522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS.
    de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis.
    Gil-Bea FJ; Aldanondo G; Lasa-Fernández H; López de Munain A; Vallejo-Illarramendi A
    Expert Rev Mol Med; 2017 Jun; 19():e7. PubMed ID: 28597807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigmented creatine deposits in Amyotrophic Lateral Sclerosis central nervous system tissues identified by synchrotron Fourier Transform Infrared microspectroscopy and X-ray fluorescence spectromicroscopy.
    Kastyak MZ; Szczerbowska-Boruchowska M; Adamek D; Tomik B; Lankosz M; Gough KM
    Neuroscience; 2010 Apr; 166(4):1119-28. PubMed ID: 20097271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.